Key market opportunities include the rising demand for AI-enhanced trial design, boosted by increasing complexity in clinical ...

PITTSBURGH, May 22, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) moves to leverage its vast biobank of more than 150,000 heterogenous live cell tumor samples and drug response data ...

Details of the model, called Path-IO, were presented today at the American Association for Cancer Research (AACR) Annual ...

Stanford Medicine has developed a vision-language artificial intelligence (AI) model that can predict cancer outcomes, such as forecasting melanoma relapses and patient responses to immunotherapy.

A deep learning platform may help predict how people with advanced lung cancer will respond to immunotherapy, according to ...

Forbes contributors publish independent expert analyses and insights. David Henkin helps organizations and individuals innovate and grow. Predictive analytics has evolved from a niche discipline into ...

Predictive Oncology, Inc. (NASDAQ:POAI) stock is trading higher on Tuesday after the company reported results from utilizing artificial intelligence (AI) for drug repurposing. The Details: Predictive ...